Insurance for a Healthcare Startup: The Year-One Stack for NY Founders

TL;DR. The right NY healthcare startup insurance stack is milestone-driven, not checklist-driven. Day-one coverage is general liability plus professional liability. Each funding round and clinical milestone triggers a specific addition: workers' comp and PFL at the first hire, cyber once PHI flows, D&O before Series A, tech E&O at revenue. Buying too little leaves founders personally exposed. Buying too much wastes scarce runway on dormant coverage.

Insurance is one of the line items a healthcare startup founder can either get right quickly or fight for two years. The difference is the sequence. CB Insights healthcare funding research and Rock Health's annual digital-health funding report both document the same pattern: founders who treat insurance as day-one plumbing rarely revisit it, and founders who defer it end up buying under time pressure at a term-sheet deadline, when options are narrower and premiums are higher. New York adds two layers that generic startup-insurance guidance misses: statutory short-term disability and Paid Family Leave from the first employee, and the Corporate Practice of Medicine doctrine that governs who can own a care-delivery entity. This guide covers the full year-one and year-two stack, the milestones that trigger each addition, the founder D&O decision most startups defer too long, the NY-specific considerations, realistic cost benchmarks, and what not to buy early.

The first policy: general liability plus professional liability at formation

Two lines carry the entire pre-revenue phase. General liability, typically written at $1M per occurrence and $2M aggregate, covers third-party bodily injury and property damage claims, the kind a landlord, a vendor, or a pilot-site partner will require before countersigning any agreement. Professional liability, typically at $1M per claim and $3M aggregate, covers claims arising from the professional services the startup renders, whether that is software advisory, consulting, or (once licensed clinicians are involved) actual care delivery. For a pre-revenue NY healthcare startup, combined premium on these two lines typically runs roughly $3K to $8K per year.

Startup underwriting differs from established-practice underwriting in both directions. There is no loss history to work against, which can help when the founding team has clean records and hurt when the underwriter needs operational history to evaluate controls. On the vendor side, the certificate of insurance is often what turns a verbal pilot conversation into a signed pilot agreement. A startup that cannot produce a certificate within 48 hours of request routinely loses pilots to competitors that can.

What the professional liability form actually covers

The professional liability form varies by what the startup does. A pure software or advisory startup typically buys a technology errors-and-omissions form (tech E&O), which covers claims arising from software defects, incorrect advice, or failure to deliver promised functionality. A startup that employs or contracts licensed clinicians to deliver care typically needs a medical professional liability (medical malpractice) form written to match the clinical services in scope; the milestone-driven checklist later in this guide walks through the seven lines most healthcare startups eventually carry, and the sequencing that makes the first year manageable. A hybrid model (software plus human clinical services) typically needs both forms, with the insuring agreements and exclusions coordinated so claims do not fall between them.

Why founders should not skip the broker conversation at formation

At formation is precisely when a broker conversation is most efficient. The startup can buy wrong coverage (a generic business owner's policy that excludes professional services) cheaply and be forced to restart in six months, or it can buy the right two lines from the start and add to them as milestones trigger. Morningside's healthcare startup risk advisory overview describes the scope; the general liability service page and professional liability service page describe the two foundational lines in more detail.

When to add each subsequent line: a milestone-driven checklist

The second lesson of year-one insurance is that each subsequent addition has a natural trigger. Adding a line before its trigger is an expense without a purpose. Adding a line after its trigger is exposure. The sequence below is the one Morningside sees work most consistently across NY healthcare startups.

First W-2 hire: workers' comp, DBL, and PFL

The first W-2 hire triggers three statutory lines that must all be in force on the first day of employment. The NY Workers' Compensation Board requires workers' compensation coverage from every private-sector employer with at least one employee, with no FTE floor and no grace period. NY Disability Benefits Law and NY Paid Family Leave apply from the first employee working 30 or more days in NY. All three are typically written together through an authorized disability-benefits carrier. The practical mechanics: workers' comp premium is based on payroll and class code, DBL is a small per-employee premium the employer can share or fully cover, and PFL is funded by an employee payroll deduction at a rate set annually by NY DFS.

Seed round closed: cyber liability sized to PHI exposure

Cyber liability is the line most often mis-sequenced. The trigger is not the funding round; it is the moment protected health information, personally identifiable information, or payment-card data starts flowing through the startup's systems. For a startup still in discovery mode with no production data, deferring cyber is defensible. For one that has signed a pilot data-sharing agreement with a health system, cyber needs to be in place before the first record transfers. Seed-stage cyber limits typically run $1M to $3M per claim. The NY SHIELD Act imposes breach-notification obligations on any business holding private information of NY residents, so "we are not technically a NY company" does not exempt the startup. The cyber insurance service page covers the coverage structure in more detail.

Series A plus first clinical pilot: HIPAA BAAs and cyber limit increase

The Series A round and the first clinical pilot almost always arrive together. Two coverage changes follow. First, every clinical partner, EHR integration, data-processing vendor, and hosting provider that touches PHI needs a HIPAA business associate agreement. These are contractual obligations rather than insurance, but the cyber policy needs to be reviewed to confirm it responds to claims arising out of PHI breaches at downstream business associates. Second, the cyber limit typically needs to step up from seed-stage $1M to $3M, into the $5M to $10M range, because a breach that involves ten thousand patient records triggers notification costs, regulatory defense costs, and civil penalties that can quickly exceed a $3M limit.

First senior hire over $150K total comp: executive benefits and founder D&O

The first senior hire is usually the moment the cap table stops being "just the founders" and the employment stakes get richer. Two coverage additions follow. Executive employee benefits (individual disability top-ups, supplemental life, any equity-linked compensation design) often start to matter when the startup is recruiting senior talent out of a hospital system or a Big Tech company. The comparison of benefits advisors, PEOs, and direct carrier relationships walks through the sourcing decision most founders face at this stage. And founder D&O becomes more urgent, because the senior hire is now also a potential plaintiff if the employment relationship ends poorly.

Revenue exceeds $500K ARR: tech E&O, product liability, and EPL

Revenue crossing $500K ARR changes the insurance conversation from "coverage for what could happen" to "coverage for what is now happening." For a digital-health software product, tech E&O limits typically increase from founder-stage levels into the $3M to $5M range. For a hardware product or a product with an embedded device, product liability becomes necessary. And employment practices liability typically gets added once the headcount sits consistently above four or five employees, because the exposure to wrongful-termination, discrimination, and harassment claims tracks much more closely with headcount than with revenue.

Venture-backed considerations: what investor due diligence will ask about

Sophisticated healthcare investors have a consistent insurance certificate schedule they expect in the data room. National Venture Capital Association model documents and most healthcare-focused venture funds' closing checklists name the same short list. Founders who know what is coming can pre-build the schedule and clear one line-item from the closing checklist.

The investor data-room insurance schedule

A Series A closing data room typically includes certificates of insurance for general liability, professional liability (tech E&O for digital-health, medical professional liability if clinical), cyber liability, founder D&O, employment practices liability, workers' compensation, and NY DBL and PFL. Investor counsel reviews the certificates for named-insured status (the fund or its board representative typically gets additional-insured status on the D&O and sometimes on the GL), for aggregate limits appropriate to the round size, and for policy-period alignment with closing. Missing a certificate at the closing table rarely scuttles a round, but it delays the wire, and delays at the closing table are expensive.

Board composition and the D&O additional-insured question

Series A lead investors almost always negotiate for named-insured or additional-insured status for their board representative on the founder D&O policy, so the fund's partner is personally indemnified for actions taken in that role. The endorsement is routine but needs to be in place before closing; a policy written without it typically requires a mid-term amendment that can take days to process. The physicians industry page covers adjacent considerations for care-delivery entities where the board composition also intersects with NY Corporate Practice of Medicine rules.

What investors want to see on the cyber policy

For a healthcare startup, the cyber policy receives more scrutiny than any other line during diligence. Investors typically want to see first-party coverage for breach response (forensics, notification, credit monitoring), third-party coverage for privacy and network security liability, regulatory coverage for NY DFS Part 500, HHS OCR, and state attorney general investigations, and PHI-specific coverage for HIPAA-related claims. Coverage for ransomware payments (where legal), business interruption, and social-engineering fraud is increasingly standard on startup-tailored forms. Our insight on the hidden cost of revenue-cycle leakage covers an adjacent operational-risk topic that often surfaces in the same diligence pass.

Founder D&O: the one most startups skip

Directors and officers liability is the line founders most consistently underestimate. D&O covers personal exposure of founders, officers, and directors for corporate decisions, not for performance of professional services (professional liability handles that). The exposure does not wait for Series A. It exists from the day the first employment decision is made, the first vendor agreement is signed, and the first investor slide deck claims revenue, market size, or regulatory position.

What D&O actually covers, and what it does not

A founder D&O policy typically covers defense costs and judgments from claims alleging breach of fiduciary duty, mismanagement, misrepresentation in financial disclosures, wrongful termination tied to corporate decisions, regulatory investigations, and some IP disputes. It typically does not cover criminal conduct, intentional fraud (after final adjudication), or bodily injury and property damage (GL handles that). The structure is a three-sided policy: Side A for individual directors and officers when the company cannot indemnify, Side B reimbursing the company when it does, and Side C for entity coverage on securities claims.

Typical NY founder D&O limits and pricing

NY startup D&O typically runs $1M to $3M in limit at pre-seed and seed stage, with annual premium in the roughly $3K to $15K range depending on stage, headcount, industry, and prior funding. Post-Series A, limits typically step up to $5M to $10M, with premium rising into the $15K to $40K range. Post-Series B, limits often reach $10M to $25M. Healthcare startups handling PHI, working with regulated devices, or operating in reimbursement gray areas typically pay premiums at the upper end of these ranges. Markets that actively write early-stage healthcare D&O include Travelers, Chubb, AIG, Hiscox, and Beazley.

Why "we are too early for D&O" is a common and expensive mistake

The most common framing Morningside hears from pre-Series A founders is that D&O is a Series A problem. It usually is not. Early-stage D&O claims arise from four places: employment decisions (wrongful termination, discrimination, harassment), regulatory inquiries (HHS, FDA, NY DFS, state attorney general), IP disputes (a co-founder or former employer alleging theft of trade secrets), and financial-disclosure issues (a pitch deck or investor update later argued to have been misleading). None wait for a term sheet. And buying D&O under time pressure at a Series A closing is more expensive than buying it six months earlier, because the underwriter has less time to evaluate the risk and prices the uncertainty.

NY-specific startup considerations: CPOM, the SHIELD Act, and the AG's enforcement posture

Three NY-specific rules shape the insurance stack for every healthcare startup incorporated or operating in the state. Generic startup-insurance guidance written for Delaware C-corps in San Francisco will miss all three, and every one of them has direct implications for how the policies are written and who is named as the insured.

Corporate Practice of Medicine: who can own a care-delivery entity

New York's Corporate Practice of Medicine doctrine, rooted in Business Corporation Law §1503 and administered through the NY Department of Education Office of the Professions, restricts ownership of care-delivery entities to licensed clinicians. A healthcare startup that employs or contracts physicians to deliver care typically cannot deliver that care through a standard LLC or C-Corp; it needs a Professional Corporation (PC) or Professional Service LLC (PLLC) owned by licensed clinicians, with a services agreement between the operating company and the PC or PLLC. The companion guide on credentialing and payer contracting for a growing NY practice covers the operational mechanics, and the adjacent guide on employee benefits for NY medical practices covers the benefits layer. For the insurance stack, the PC or PLLC typically carries its own medical professional liability policy naming the clinicians, while the operating company carries tech E&O, cyber, and D&O. Coordinating the two policies so the insuring agreements and the services agreement all point at the same facts is work that belongs at formation, not at the first claim.

The NY SHIELD Act and GBL §349: the AG's digital-health enforcement posture

The NY SHIELD Act and NY General Business Law §349 together give the NY Attorney General broad authority over digital-health data practices. SHIELD imposes reasonable-safeguards and breach-notification obligations on any business holding private information of NY residents. GBL §349, the state's consumer-protection statute, has been used aggressively by recent AG offices against health-adjacent businesses for deceptive practices in marketing, privacy representations, and data handling. The cyber policy needs to respond to AG investigations, not just class-action lawsuits, and the regulatory coverage sublimit is worth inspecting before a startup sends its first marketing email to NY users.

NY Medicaid waiver and regulatory gray areas

Pilot-stage care-model startups (AI triage, remote monitoring, population-health platforms, digital therapeutics) frequently operate in regulatory gray areas where the service is not yet recognized under existing reimbursement codes. The NY Department of Health Medicaid innovation and waiver programs cover some of this space, but every gray area translates into a professional-liability coverage question: does the policy's insuring agreement match the services actually being delivered, or does the carrier consider the service outside what was represented in underwriting? For pilots running under a NY Medicaid waiver or a health-system research agreement, the professional-liability form should be reviewed by broker and counsel before the pilot launches.

Costs by stage: what year-one, year-two, and year-three insurance spend looks like

Total insurance spend for a NY healthcare startup scales with headcount, PHI exposure, and funding stage. The ranges below reflect what Morningside sees across NY healthcare startup clients in 2026 and should be read as ranges, not point estimates.

Year one: pre-Series A, under 10 FTE

A pre-revenue or early-revenue NY healthcare startup under 10 FTE typically spends roughly $8K to $18K per year across the full stack. The composition is usually general liability and professional liability at roughly $3K to $8K, seed-stage cyber at roughly $2K to $5K, workers' comp and statutory DBL and PFL at a few hundred dollars on a small payroll, and founder D&O (if bought) at roughly $3K to $15K. A startup that defers cyber and D&O can run the year-one number closer to $5K to $10K, but at the cost of exposure that compounds once PHI flows or once a senior hire creates employment-related D&O risk.

Year two: post-Series A, 10 to 30 FTE

A post-Series A NY healthcare startup with 10 to 30 FTE typically spends roughly $25K to $60K per year. The composition shifts: D&O limits rise into the $3M to $10M range with premium in the $15K to $40K band, cyber limits move to $5M to $10M with premium in the $10K to $25K range, employment practices liability gets added at roughly $3K to $10K, and workers' comp scales with the payroll. Professional-liability (tech E&O or medical) premiums also move up as revenue grows and as coverage limits increase.

Year three: post-Series B, 30 plus FTE

A post-Series B NY healthcare startup with 30 or more FTE typically spends roughly $75K to $200K per year, with the spread driven mostly by whether the product is software-only or includes a regulated device or clinical service. The D&O layer at this stage typically runs $10M to $25M in limit, with primary and excess layers assembled across multiple carriers. Cyber at this stage typically sits at $10M to $25M. Tech E&O and product liability, for products that have reached commercial scale, are often the largest single line in the stack.

What not to buy year one

The flip side of milestone-driven insurance is milestone-driven self-restraint. Four common over-purchases show up in first-year healthcare startup programs and rarely pay off.

High-limit cyber before PHI flows is the most common. A pre-product startup with no patient or user data does not need a $5M cyber tower. A $1M to $3M limit tracks the actual exposure at that stage, and the limit scales up once data starts moving. Paying for a $10M limit in year one, when there is no PHI and no revenue, is roughly $15K to $20K of premium spent on risk that does not yet exist.

Errors and omissions coverage tied to revenue can similarly be deferred until revenue exists. A company that has signed no commercial contract has, by definition, no contractual-performance exposure yet. Founder-stage professional liability at a $1M limit covers what needs covering; the step-up to higher limits belongs when revenue does.

Medical malpractice coverage for an organization that does not yet employ or contract licensed providers is the third. If the startup is in a pure-software discovery phase with no clinicians in the workflow, a medical malpractice form is the wrong product; tech E&O or a general professional-liability form fits the actual work. Buying medical malpractice early creates the worst of both worlds: premium paid on coverage that is not yet being triggered, with a form that may need to be rewritten once clinicians actually join.

Key person coverage on a three-person founding team is the fourth. Key person life insurance makes sense when the company's enterprise value would materially collapse on the loss of a specific individual and the proceeds would fund continuity or buyout. At three founders and pre-revenue, the enterprise value is not yet at a level where the proceeds justify the annual premium.

The general rule is: wait until the exposure is real, and step into coverage with each round. Founders who front-load the insurance stack at formation typically run out of runway three months earlier than they need to, and the coverage they paid for rarely responds to a claim because the claim scenario was not yet live.

A 30-minute consultation with a broker who has written NY healthcare startup programs is usually the fastest way to map the current stage against the full milestone sequence. For founders who want the full advisory scope (carrier selection, coverage sizing, investor-data-room certificate preparation, NY Corporate Practice of Medicine coordination with counsel), Morningside's healthcare startup risk advisory covers the work end to end, and the adjacent healthcare management advisory service covers the operational layer once the startup is post-Series A.